Keith Block, MD, is cofounder and medical and scientific director of Block Center for Integrative Cancer Treatment and director of integrative medical education at the University of Illinois College of Medicine, Chicago. He is also the author of the 2008 book, Life Over Cancer.
An internationally recognized expert in integrative oncology, Block combines cutting-edge conventional treatment with individualized and scientifically based complementary and nutraceutical therapies. In 1980, he cofounded the Block Center for Integrative Cancer Treatment located in Evanston, Illinois, the first such cancer treatment facility in North America. It has since become one of the world’s leading cancer treatment facilities.
The field of integrative oncology was formally recognized when Integrative Cancer Therapies was launched. In 2000, Block was invited by Sage Science Press to be the founding editor-in-chief of this peer-reviewed journal, the first medical journal devoted to exploring the research and science behind integrative oncology. “Integrative complementary incorporates the best of conventional interventions with meaningful complementary therapies, and individualizes each patient’s care regimen,” Block says.
Additionally, Block is the scientific director of the Institute for Integrative Cancer Research and Education, where he has collaborated with colleagues at the University of Illinois at Chicago, the University of Texas MD Anderson Cancer Center in Houston, and Bar Ilan University in Israel. In 2005, Block was appointed to the National Cancer Institute’s Physician Data Query Cancer CAM Editorial Board, on which he continues to serve.
Keith Block has published more than 75 scientific papers and numerous articles relevant to nutritional and integrative oncology. His Life Over Cancer offers a variety of options for people to fight cancer at the many stages of the cancer continuum, from for those recently diagnosed, to those in treatment, to those who’ve concluded treatment and need to remain vigilant to prevent recurrence.